Polo-like kinase 1 facilitates loss of Pten tumor suppressor-induced prostate cancer formation - Wikidata - awgldk - TriplyDB

Polo-like kinase 1 facilitates loss of Pten tumor suppressor-induced prostate cancer formation

Polo-like kinase 1 facilitates loss of Pten tumor suppressor-induced prostate cancer formation

http://www.wikidata.org/entity/Q35371690

about

Polo-like kinase 1, on the rise from cell cycle regulation to prostate cancer development Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancer Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications Tumor suppressor protein DAB2IP participates in chromosomal stability maintenance through activating spindle assembly checkpoint and stabilizing kinetochore-microtubule attachments.Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer.Posttranslational regulation of phosphatase and tensin homolog (PTEN) and its functional impact on cancer behaviors.Multiple host kinases contribute to Akt activation during Salmonella infection.Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer PTEN: Multiple Functions in Human Malignant Tumors Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment The APC/C Ubiquitin Ligase: From Cell Biology to Tumorigenesis FOXM1 participates in PLK1-regulated cell cycle progression in renal cell cancer cells.Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation The role of polo-like kinase 1 in carcinogenesis: cause or consequence?Current assessment of polo-like kinases as anti-tumor drug targets.Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics.Plk1 inhibition enhances the efficacy of androgen signaling blockade in castration-resistant prostate cancer.Large-scale label-free comparative proteomics analysis of polo-like kinase 1 inhibition via the small-molecule inhibitor BI 6727 (Volasertib) in BRAF(V600E) mutant melanoma cells.Plk1-dependent microtubule dynamics promotes androgen receptor signaling in prostate cancer Cell Cycle Control by PTEN.PTEN regulates PLK1 and controls chromosomal stability during cell division Inhibition of Plk1 represses androgen signaling pathway in castration-resistant prostate cancer.The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis.PTEN in the maintenance of genome integrity: From DNA replication to chromosome segregation.Inhibition of Prostate Smooth Muscle Contraction by Inhibitors of Polo-Like Kinases.

P2860

Q26825016-FB54AC0B-59EC-4314-B0AF-1B4BF822969E Q27024775-65ED01A8-B3ED-4132-8BFD-8341494503FA Q28076060-27B46F96-FFF1-42EC-BFD6-7885291CD4E2 Q30822011-C85CC9AD-3768-4FE6-AE4C-1AFF4F488077 Q34042731-B47822AF-9FC9-4DB0-8D34-5375BDB4F3EA Q34353848-C25670D4-C7A5-41E6-A3AC-9BB0759F4511 Q34976965-EB66B6CC-A067-4421-B706-7EAAB650F529 Q35007438-89FAF8AD-3ACA-4906-BD01-A1A95E1C3D6A Q35087328-D34DEE31-F735-4E44-A237-CAF6100A1B42 Q35801683-B7CCBA52-A1DD-4A04-A617-2AFFB64087D9 Q35971862-6F58398F-69D1-4338-B40D-34B34DAF6E48 Q36741118-95EDE3C6-3341-4F3D-85B5-314F5AFF016A Q37126130-C1A00414-96B9-4CBD-A7C1-BD57DA333A10 Q38165149-639A1F03-45D3-4AEB-8203-A80FC7ABF0E3 Q38211244-E7574BFA-AA37-4C05-8D59-093BCA7E59E2 Q38559278-7CE87495-DA1A-4552-A97B-0335E3A76CC5 Q38872725-B1F50E6B-6DAC-4E05-BA1E-18A9DC333132 Q38953636-4D580D54-2298-4288-9210-C2374E7FA598 Q38989539-76001A25-AF8D-4E5E-8E95-B06E06617198 Q39153868-07D7E955-C231-47B5-8FD0-2FF80B4E0C26 Q39365401-700755D2-C0B1-4C40-9395-93C88CB42781 Q39615345-FF58FA1B-67F7-4884-B0E5-494A67F5C873 Q43211192-1E9D4988-3E67-410B-AB70-E166A8C30FCC Q45068538-F005DA63-21B3-4CA3-8FBF-01CAFA94BA06 Q50168053-3392E9C5-4F4B-43F4-89BB-207C6BAD599D Q55361601-49499A27-CA1D-4F04-A35D-21C2B7185F23

P2860

Polo-like kinase 1 facilitates loss of Pten tumor suppressor-induced prostate cancer formation

http://www.wikidata.org/entity/Q35371690

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Polo-like kinase 1 facilitates ...... uced prostate cancer formation

@ast

Polo-like kinase 1 facilitates ...... uced prostate cancer formation

@en

type

label

Polo-like kinase 1 facilitates ...... uced prostate cancer formation

@ast

Polo-like kinase 1 facilitates ...... uced prostate cancer formation

@en

prefLabel

Polo-like kinase 1 facilitates ...... uced prostate cancer formation

@ast

Polo-like kinase 1 facilitates ...... uced prostate cancer formation

@en

P1433

Q35371690-E3FF5F62-B146-447F-951A-A5725DD2BC9E

P1476

Q35371690-AA307B96-54C6-4664-989E-95D5B9DF1F75

P2093

Q35371690-2CE80C42-22F1-4BF3-B58B-FB09D280D07C

Q35371690-44504692-8CD4-46C4-9031-D8E2EC3B8F7B

Q35371690-5AFDF730-96F2-4AC4-8D51-302C481294C0

Q35371690-A2E9DA16-28C4-46F2-B276-2A37E6CFAEFA

Q35371690-BE3EE016-2DAF-45B8-87FF-44686BC4FBE5

Q35371690-C5FFC789-8AE0-43C3-A362-6821E024B07E

Q35371690-D5BF3E6A-64CC-49F9-A7D4-31E31023DF6F

Q35371690-DBA90B0E-4CA2-4A34-80B3-BFB61D3BD88C

P2860

Q35371690-03814632-A23E-42AF-BEA5-4DBE9947060A

Q35371690-067078B9-49FC-476D-A060-657875D6141D

Q35371690-0826DF8C-3203-4886-8FF8-6C2D52661FBD

Q35371690-092C6803-4080-4F21-89BA-8ACAFD1EB025

Q35371690-11C1CB66-792D-4887-B436-0A9185C694B7

Q35371690-1FC05C26-87A0-4EC2-925D-CAFD851BDE26

Q35371690-2B4E2A9F-D432-40AC-8D95-46718CAAACD7

Q35371690-2EB7BFCB-A25F-4557-A51A-071B498830B0

Q35371690-5C3D15DA-844F-4422-BE40-3691C3A796E2

Q35371690-66CCBF2F-3A02-475D-815C-711C3853BD86

P304

Q35371690-E2162A15-16C4-4447-A8F3-6A8CBCA0D0DC

P31

Q35371690-1C325EEE-CA6F-4356-AA86-D3A83D3A8951

P356

Q35371690-7EA4A02D-DBF4-460F-8A71-E79DB2E2D4FD

P407

Q35371690-9586F315-3AA1-46F9-85AA-F34C7B8BDD3D

P433

Q35371690-955B4B51-F3A1-4758-8E77-F5A232FC4AB3

P478

Q35371690-C5049C36-F8B4-45DC-8653-76BEBD64BB61

P577

Q35371690-32F6C163-66E9-4F8B-8AFE-3E7E7E9EA566

P5875

Q35371690-20CBA66E-AF6D-48CF-B6DF-A0C445EB43EF

P698

Q35371690-20B481F1-D437-413F-B4AB-46C4E2F6F722

P932

Q35371690-FD429B2E-8BB2-4BB4-950F-1A9F20D2370F

P356

JBC.C111.269050

P1433

Journal of Biological Chemistry

P1476

Polo-like kinase 1 facilitates ...... uced prostate cancer formation

@en

P2093

Bennett D Elzey

http://www.w3.org/2001/XMLSchema#string

Bing Song

http://www.w3.org/2001/XMLSchema#string

Liang Cheng

http://www.w3.org/2001/XMLSchema#string

Nihal Ahmad

http://www.w3.org/2001/XMLSchema#string

Stephen F Konieczny

http://www.w3.org/2001/XMLSchema#string

Timothy L Ratliff

http://www.w3.org/2001/XMLSchema#string

X Shawn Liu

http://www.w3.org/2001/XMLSchema#string

Xiaoqi Liu

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

Polo-like kinase 1 phosphorylation of G2 and S-phase-expressed 1 protein is essential for p53 inactivation during G2 checkpoint recovery

Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner

Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

Essential role for nuclear PTEN in maintaining chromosomal integrity

PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway

Principles of cancer therapy: oncogene and non-oncogene addiction

Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Res

P304

35795-35800

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.C111.269050

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

286

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51617882

http://www.w3.org/2001/XMLSchema#string

P698

21890624

http://www.w3.org/2001/XMLSchema#string

P932

3195584

http://www.w3.org/2001/XMLSchema#string